Colorectal Cancer Incidence Patterns in the United States, 1974–2013
By R. Siegel, S. Fedewa, W. Anderson, K. Miller, Jiemin Ma, P. Rosenberg, A. Jemal. Journal of the National Cancer Institute, 2017
1,111 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/af788e28dc2bf5299233922a3a872ac6387454a2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- R. Siegel
- Lindsey A. Torre
- A. Jemal
- A. Shaukat
- Jennifer S. Lin
- Charles J. Kahi
- Isabelle Soerjomataram
- N. S. Wagle
Citations in the corpus
- Colorectal cancer statistics, 2023 (2023, result): “In contrast to decreasing CRC incidence in older adults, rates have been increasing in adults aged 20–39 years since the mid‐1980s and in those aged 40–54 years since the mid‐ 1990s.(44) From 2011 through 2019, rates increased by 1.”
- Clinical sequencing defines the genomic landscape of metastatic colorectal cancer (2018, background): “…common cause of cancer deaths worldwide (Siegel et al., 2017a), and there is a growing incidence of CRC, often metastatic, among younger patients (Siegel et al., 2017b). mCRC, however, can exhibit a range of clinical behavior, from curable oligometastatic disease to rapidly progressing fatal…”
- Global patterns and trends in colorectal cancer incidence in young adults (2019, background): “This likely hindered our ability to detect the steeper rise for rectal than for colon cancer that has been reported by numerous studies of early-onset CRC trends excluding appendix, 5 9 11 but less often by those including appendix.”
- ACG Clinical Guidelines: Colorectal Cancer Screening 2021. (2021, methodology): “It has been estimated that persons born around 1990 have twice the risk of colon cancer and 4 times the risk of rectal cancer compared with those born around 1950 (80).”
- Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. (2021, methodology): “For KQ1, the syntheses were organized into 3 main categories: (1) trials designed to assess the effectiveness (intention to screen) of screening tests compared with no screening; (2) observational studies designed to assess the association of receipt of a screening test compared with no screening; a”